|
Indications for Bone Density Testing [36] (Official Position of the International Society for Clinical Densitometry). |
| 1. All women aged 65 and older. |
| 2. Postmenopausal women under age 65 with risk factors for osteoporosis. |
| 3. Adults with a fragility fracture. |
| 4. Adults with a disease or condition associated with low bone mass or bone loss. |
| 5. Adults taking medication associated with low bone mass or bone loss. |
| 6. Anyone being treated for low bone mass, to monitor treatment effect. |
| 7. Anyone not receiving therapy, in whom evidence of bone loss would lead to treatment. |
|
Women discontinuing estrogen should be considered for bone density testing/bone mass measurement according to the indications listed above. These indications provide a framework for selecting patients for bone density testing. In order to determine if the test is covered by insurance, it is important to be familiar with local requirements. |
Lewiecki Clinical and Molecular Allergy 2004 2:9 doi:10.1186/1476-7961-2-9 |